Screening Strategies in Drug Discovery – News and Features

Evotec will apply their skills and technologies to identify biologically active molecules from its corporate library.

Fisher acquires BioImage to expand its offering in high content screening and analysis reagent technologies.

The project is the only large-scale structural biology project in the NIH program that will focus on a single organism.

The authors reported the creation of a lentiviral shRNA library to knock down genes for genome-wide screening.

The Computational Medicine Center has purchases Evotec Technologies’ ultra-High-Throughput Screening system including cellular imaging technologies.

SBS to present seven short courses during the Society for Biomolecular Science's 12th Annual Conference & Exhibition.

Agreement expands use of proprietary transgenic zebrafish technology, Z-Tag(SM), in Drug Discovery.

The Computational Medicine Center (CMC), an Ohio Third Frontier-funded research collaboration between Cincinnati Children's and UC, has purchased Evotec Technologies' ultra-High-Throughput Screening (uHTS) system.

Research and Markets adds the Decision Resources report "Protein-Protein Interactions: Are They Now Druggable Targets?" to their offering.

Blue Sky will provide pharma-grade proteins that pharmaceutical companies can quickly screen against their entire small molecule libraries.